Molecular Analysis of Salivary and Lacrimal Adenoid Cystic Carcinoma

Adenoid cystic carcinoma (ACC) of head and neck origin is associated with slow but relentless progression and systemic metastasis, resulting in poor long-term survival rates. ACC does not respond to conventional chemotherapy. Determination of molecular drivers may provide a rational basis for person...

Full description

Saved in:
Bibliographic Details
Published in:Cancers 2024-08, Vol.16 (16), p.2868
Main Authors: Powell, Sarah, Kulakova, Karina, Hanratty, Katie, Khan, Rizwana, Casserly, Paula, Crown, John, Walsh, Naomi, Kennedy, Susan
Format: Article
Language:English
Subjects:
Adenoid
Angiogenesis
Cancer
Chemotherapy
Chromosome 6
Development and progression
DNA sequencing
Drug development
Epigenetic inheritance
Epigenetics
Exocrine glands
Fluorescence in situ hybridization
Genes
Genetic aspects
Genomes
Genomics
Head and neck carcinoma
Health aspects
Histology
Lacrimal gland and Nasolacrimal duct
Medical prognosis
Metastases
Metastasis
Mutation
Notch protein
Pathogenesis
Patients
Physiological aspects
Prognosis
Radiation therapy
Salivary gland
Salivary gland tumors
Survival
Therapeutic targets
Tumors
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Adenoid cystic carcinoma (ACC) of head and neck origin is associated with slow but relentless progression and systemic metastasis, resulting in poor long-term survival rates. ACC does not respond to conventional chemotherapy. Determination of molecular drivers may provide a rational basis for personalized therapy. Herein, we investigate the clinical and detailed molecular genomic features of a cohort of patients treated in Ireland and correlate the site of origin, molecular features, and outcomes. Clinical and genomic landscapes of all patients diagnosed with ACC over a twenty-year period (2002-2022) in a single unit in Ireland were examined and analyzed using fluorescence in situ hybridization, DNA sequencing, and bioinformatic analysis. Fourteen patients were included for analysis. Eleven patients had primary salivary gland ACC and three primary lacrimal gland ACC; 76.9% of the analyzed tumors displayed evidence of - rearrangement at the 6q23.3 locus; 35% had mutations in pathway genes; 7% of patients had a mutation, 14.3% mutation, and 14.3% mutation. The presence of epigenetic modifications in ACC patients significantly correlated with worse overall survival. Our study identifies genetic mutations and signaling pathways that drive ACC pathogenesis, representing potential molecular and therapeutic targets.
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers16162868